In8Bio (INAB) Research & Development (2020 - 2026)

In8Bio has disclosed Research & Development across 7 years of filings, most recently posting $2.5 million for Q2 2026.

• In Q2 2026, Research & Development changed 0.24% year-over-year to $2.5 million; the TTM figure through Jun 2026 stood at $9.9 million (down 20.26% YoY), while the FY2025 annual figure was $10.2 million, down 39.8% from the prior year.
• Research & Development came in at $2.5 million for Q2 2026 at In8Bio, down from $2.6 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $5.2 million in Q2 2024 to a low of $2.1 million in Q3 2025.
• Average Research & Development over 5 years is $3.5 million, with a median of $3.5 million recorded in 2022.
• Year-over-year, Research & Development soared 215.19% in 2022 and tumbled 51.76% in 2025.
• Over 5 years, Research & Development stood at $3.9 million in 2022, then increased by 15.3% to $4.5 million in 2023, then fell by 20.52% to $3.6 million in 2024, then retreated by 26.32% to $2.6 million in 2025, then declined by 5.85% to $2.5 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $2.5 million in Q2 2026, $2.6 million in Q1 2026, and $2.6 million in Q4 2025.